MedPath

International Melanoma Algorithm Training Study - IMATS

Not Applicable
Completed
Conditions
Malignant Melanoma
Registration Number
NCT00966173
Lead Sponsor
SciBase AB
Brief Summary

This is an international, multicenter, prospective, non controlled, non randomized, clinical study to collect electrical impedance data of potentially malignant pigmented nevi and histological diagnoses (International Melanoma Algorithm Training Study \[IMATS\]). The study objective is to collect data for training and optimization of an algorithm that can classify skin lesions using electrical impedance, i.e., to identify malignant melanomas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1800
Inclusion Criteria
  • Men and women of any ethnic group
  • Lesion located on normal healthy skin
  • Maximum number of eight lesions per patient
  • etc.
Exclusion Criteria
  • Lesion under finger and toe nails
  • Lesion located on eczema, psoriasis areas or similar
  • Lesion located on scars
  • etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Outcome measure not applicable. This is an algorithm training study.Q1 2010
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sahlgrenska University Hospital, Dpt. of Dermatology

🇸🇪

Gothenburg, Sweden

© Copyright 2025. All Rights Reserved by MedPath